vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and NOODLES & Co (NDLS). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $122.1M, roughly 1.7× NOODLES & Co). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -7.5%, a 64.9% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-2.8M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
IDYA vs NDLS — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $122.1M |
| Net Profit | $119.2M | $-9.2M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | -5.2% |
| Net Margin | 57.4% | -7.5% |
| Revenue YoY | — | -4.1% |
| Net Profit YoY | 330.1% | 32.8% |
| EPS (diluted) | $1.33 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $207.8M | $122.1M | ||
| Q2 25 | — | $123.8M | ||
| Q4 24 | — | $122.8M | ||
| Q3 24 | $0 | $127.4M | ||
| Q2 24 | $0 | $121.4M | ||
| Q1 24 | $0 | $124.3M | ||
| Q4 23 | — | $127.9M | ||
| Q3 23 | — | $125.2M |
| Q3 25 | $119.2M | $-9.2M | ||
| Q2 25 | — | $-9.1M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | $-51.8M | $-13.6M | ||
| Q2 24 | $-52.8M | $-6.1M | ||
| Q1 24 | $-39.6M | $-6.1M | ||
| Q4 23 | — | $700.0K | ||
| Q3 23 | — | $-1.3M |
| Q3 25 | 52.2% | -5.2% | ||
| Q2 25 | — | -5.2% | ||
| Q4 24 | — | -3.9% | ||
| Q3 24 | — | -9.0% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | — | -3.7% | ||
| Q4 23 | — | 1.6% | ||
| Q3 23 | — | -0.2% |
| Q3 25 | 57.4% | -7.5% | ||
| Q2 25 | — | -7.3% | ||
| Q4 24 | — | -5.5% | ||
| Q3 24 | — | -10.7% | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | — | -4.9% | ||
| Q4 23 | — | 0.5% | ||
| Q3 23 | — | -1.0% |
| Q3 25 | $1.33 | $-0.20 | ||
| Q2 25 | — | $-0.20 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | $-0.60 | $-0.30 | ||
| Q2 24 | $-0.68 | $-0.14 | ||
| Q1 24 | $-0.53 | $-1.64 | ||
| Q4 23 | — | $0.02 | ||
| Q3 23 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $-38.9M |
| Total Assets | $1.2B | $280.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $786.9M | $4.7M | ||
| Q2 25 | — | $1.4M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $920.0M | $1.8M | ||
| Q2 24 | $701.7M | $1.3M | ||
| Q1 24 | $698.8M | $3.0M | ||
| Q4 23 | — | $2.5M | ||
| Q3 23 | — | $3.1M |
| Q3 25 | $1.1B | $-38.9M | ||
| Q2 25 | — | $-13.9M | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | $1.2B | $9.6M | ||
| Q2 24 | $931.7M | $21.9M | ||
| Q1 24 | $935.3M | $27.2M | ||
| Q4 23 | — | $32.5M | ||
| Q3 23 | — | $36.1M |
| Q3 25 | $1.2B | $280.6M | ||
| Q2 25 | — | $319.4M | ||
| Q4 24 | — | $340.5M | ||
| Q3 24 | $1.2B | $346.3M | ||
| Q2 24 | $973.7M | $360.4M | ||
| Q1 24 | $961.5M | $368.1M | ||
| Q4 23 | — | $368.8M | ||
| Q3 23 | — | $357.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $4.3M |
| Free Cash FlowOCF − Capex | $142.2M | $-2.8M |
| FCF MarginFCF / Revenue | 68.4% | -2.3% |
| Capex IntensityCapex / Revenue | 0.0% | 5.8% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $142.2M | $4.3M | ||
| Q2 25 | — | $4.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $-49.2M | $4.7M | ||
| Q2 24 | $-32.9M | $7.0M | ||
| Q1 24 | $-43.8M | $164.0K | ||
| Q4 23 | — | $16.9M | ||
| Q3 23 | — | $3.2M |
| Q3 25 | $142.2M | $-2.8M | ||
| Q2 25 | — | $1.1M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | $-49.7M | $-4.5M | ||
| Q2 24 | $-33.9M | $-1.6M | ||
| Q1 24 | $-45.1M | $-15.2M | ||
| Q4 23 | — | $4.1M | ||
| Q3 23 | — | $-10.3M |
| Q3 25 | 68.4% | -2.3% | ||
| Q2 25 | — | 0.9% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | -12.2% | ||
| Q4 23 | — | 3.2% | ||
| Q3 23 | — | -8.2% |
| Q3 25 | 0.0% | 5.8% | ||
| Q2 25 | — | 2.4% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | — | 12.3% | ||
| Q4 23 | — | 10.0% | ||
| Q3 23 | — | 10.8% |
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 24.21× | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
